TY - GEN
T1 - Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells
AU - Kajiyama, Hiroaki
AU - Shibata, Kiyosumi
AU - Terauchi, Mikio
AU - Ino, Kazuhiko
AU - Nawa, Akihiro
AU - Kikkawa, Fumitaka
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2006/11
Y1 - 2006/11
N2 - Dipeptidyl peptidase IV (DPPIV) is a multifunctional cell surface aminopeptidase with ubiquitous expression and it has a variety of functional properties in the development of human malignancies. In the present study, we showed the possible correlation between DPPIV/CD26 expression and less migratory potential with decreased MMP-2 expression in ovarian carcinoma cells. Moreover, induction of DPPIV/CD26 resulted in reduced expressions of MMP-2 and mesenchymal markers such as vimentin and SMA, with a less invasive potential and an epithelial morphologic change. This evidence implies that DPPIV/CD26 may play a crucial role in the antimetastatic potential in ovarian carcinoma.
AB - Dipeptidyl peptidase IV (DPPIV) is a multifunctional cell surface aminopeptidase with ubiquitous expression and it has a variety of functional properties in the development of human malignancies. In the present study, we showed the possible correlation between DPPIV/CD26 expression and less migratory potential with decreased MMP-2 expression in ovarian carcinoma cells. Moreover, induction of DPPIV/CD26 resulted in reduced expressions of MMP-2 and mesenchymal markers such as vimentin and SMA, with a less invasive potential and an epithelial morphologic change. This evidence implies that DPPIV/CD26 may play a crucial role in the antimetastatic potential in ovarian carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=34447526600&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447526600&partnerID=8YFLogxK
U2 - 10.1196/annals.1377.007
DO - 10.1196/annals.1377.007
M3 - Conference contribution
C2 - 17185520
AN - SCOPUS:34447526600
SN - 1573316555
SN - 9781573316552
T3 - Annals of the New York Academy of Sciences
SP - 233
EP - 240
BT - Integrated Molecular Medicine for Neuronal and Neoplastic Disorders
PB - Blackwell Publishing Inc.
ER -